The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells

Michele Cioffi, Sara M. Trabulo, Yolanda Sanchez-Ripoll, Irene Miranda-Lorenzo, Enza Lonardo, Jorge Dorado, Catarina Reis Vieira, Juan Carlos Ramirez, Manuel Hidalgo, Alexandra Aicher, Stephan Hahn, Bruno Sainz, Christopher Heeschen

Research output: Contribution to journalArticle

Abstract

Objective Cancer stem cells (CSCs) represent the root of many solid cancers including pancreatic ductal adenocarcinoma, are highly chemoresistant and represent the cellular source for disease relapse. However the mechanisms involved in these processes still need to be fully elucidated. Understanding the mechanisms implicated in chemoresistance and metastasis of pancreatic cancer is critical to improving patient outcomes. Design Micro-RNA (miRNA) expression analyses were performed to identify functionally defining epigenetic signatures in pancreatic CSC-enriched sphere-derived cells and gemcitabine-resistant pancreatic CSCs. Results We found the miR-17-92 cluster to be downregulated in chemoresistant CSCs versus non-CSCs and demonstrate its crucial relevance for CSC biology. In particular, overexpression of miR-17-92 reduced CSC self-renewal capacity, in vivo tumourigenicity and chemoresistance by targeting multiple NODAL/ACTIVIN/TGF-β1 signalling cascade members as well as directly inhibiting the downstream targets p21, p57 and TBX3. Overexpression of miR-17-92 translated into increased CSC proliferation and their eventual exhaustion via downregulation of p21 and p57. Finally, the translational impact of our findings could be confirmed in preclinical models for pancreatic cancer. Conclusions Our findings therefore identify the miR-17-92 cluster as a functionally determining family of miRNAs in CSCs, and highlight the putative potential of developing modulators of this cluster to overcome drug resistance in pancreatic CSCs.

Original languageEnglish (US)
Pages (from-to)1936-1948
Number of pages13
JournalGut
Volume64
Issue number12
DOIs
StatePublished - Dec 1 2015
Externally publishedYes

Fingerprint

Neoplastic Stem Cells
Pancreatic Neoplasms
gemcitabine
MicroRNAs
Down-Regulation
Drug Resistance
Epigenomics
Cell Biology
Adenocarcinoma
Stem Cells
Cell Proliferation
Neoplasm Metastasis
Recurrence

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Cioffi, M., Trabulo, S. M., Sanchez-Ripoll, Y., Miranda-Lorenzo, I., Lonardo, E., Dorado, J., ... Heeschen, C. (2015). The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells. Gut, 64(12), 1936-1948. https://doi.org/10.1136/gutjnl-2014-308470

The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells. / Cioffi, Michele; Trabulo, Sara M.; Sanchez-Ripoll, Yolanda; Miranda-Lorenzo, Irene; Lonardo, Enza; Dorado, Jorge; Vieira, Catarina Reis; Ramirez, Juan Carlos; Hidalgo, Manuel; Aicher, Alexandra; Hahn, Stephan; Sainz, Bruno; Heeschen, Christopher.

In: Gut, Vol. 64, No. 12, 01.12.2015, p. 1936-1948.

Research output: Contribution to journalArticle

Cioffi, M, Trabulo, SM, Sanchez-Ripoll, Y, Miranda-Lorenzo, I, Lonardo, E, Dorado, J, Vieira, CR, Ramirez, JC, Hidalgo, M, Aicher, A, Hahn, S, Sainz, B & Heeschen, C 2015, 'The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells', Gut, vol. 64, no. 12, pp. 1936-1948. https://doi.org/10.1136/gutjnl-2014-308470
Cioffi M, Trabulo SM, Sanchez-Ripoll Y, Miranda-Lorenzo I, Lonardo E, Dorado J et al. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells. Gut. 2015 Dec 1;64(12):1936-1948. https://doi.org/10.1136/gutjnl-2014-308470
Cioffi, Michele ; Trabulo, Sara M. ; Sanchez-Ripoll, Yolanda ; Miranda-Lorenzo, Irene ; Lonardo, Enza ; Dorado, Jorge ; Vieira, Catarina Reis ; Ramirez, Juan Carlos ; Hidalgo, Manuel ; Aicher, Alexandra ; Hahn, Stephan ; Sainz, Bruno ; Heeschen, Christopher. / The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells. In: Gut. 2015 ; Vol. 64, No. 12. pp. 1936-1948.
@article{b67257272ee242be9af5fb4b721c5d73,
title = "The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells",
abstract = "Objective Cancer stem cells (CSCs) represent the root of many solid cancers including pancreatic ductal adenocarcinoma, are highly chemoresistant and represent the cellular source for disease relapse. However the mechanisms involved in these processes still need to be fully elucidated. Understanding the mechanisms implicated in chemoresistance and metastasis of pancreatic cancer is critical to improving patient outcomes. Design Micro-RNA (miRNA) expression analyses were performed to identify functionally defining epigenetic signatures in pancreatic CSC-enriched sphere-derived cells and gemcitabine-resistant pancreatic CSCs. Results We found the miR-17-92 cluster to be downregulated in chemoresistant CSCs versus non-CSCs and demonstrate its crucial relevance for CSC biology. In particular, overexpression of miR-17-92 reduced CSC self-renewal capacity, in vivo tumourigenicity and chemoresistance by targeting multiple NODAL/ACTIVIN/TGF-β1 signalling cascade members as well as directly inhibiting the downstream targets p21, p57 and TBX3. Overexpression of miR-17-92 translated into increased CSC proliferation and their eventual exhaustion via downregulation of p21 and p57. Finally, the translational impact of our findings could be confirmed in preclinical models for pancreatic cancer. Conclusions Our findings therefore identify the miR-17-92 cluster as a functionally determining family of miRNAs in CSCs, and highlight the putative potential of developing modulators of this cluster to overcome drug resistance in pancreatic CSCs.",
author = "Michele Cioffi and Trabulo, {Sara M.} and Yolanda Sanchez-Ripoll and Irene Miranda-Lorenzo and Enza Lonardo and Jorge Dorado and Vieira, {Catarina Reis} and Ramirez, {Juan Carlos} and Manuel Hidalgo and Alexandra Aicher and Stephan Hahn and Bruno Sainz and Christopher Heeschen",
year = "2015",
month = "12",
day = "1",
doi = "10.1136/gutjnl-2014-308470",
language = "English (US)",
volume = "64",
pages = "1936--1948",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "12",

}

TY - JOUR

T1 - The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells

AU - Cioffi, Michele

AU - Trabulo, Sara M.

AU - Sanchez-Ripoll, Yolanda

AU - Miranda-Lorenzo, Irene

AU - Lonardo, Enza

AU - Dorado, Jorge

AU - Vieira, Catarina Reis

AU - Ramirez, Juan Carlos

AU - Hidalgo, Manuel

AU - Aicher, Alexandra

AU - Hahn, Stephan

AU - Sainz, Bruno

AU - Heeschen, Christopher

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Objective Cancer stem cells (CSCs) represent the root of many solid cancers including pancreatic ductal adenocarcinoma, are highly chemoresistant and represent the cellular source for disease relapse. However the mechanisms involved in these processes still need to be fully elucidated. Understanding the mechanisms implicated in chemoresistance and metastasis of pancreatic cancer is critical to improving patient outcomes. Design Micro-RNA (miRNA) expression analyses were performed to identify functionally defining epigenetic signatures in pancreatic CSC-enriched sphere-derived cells and gemcitabine-resistant pancreatic CSCs. Results We found the miR-17-92 cluster to be downregulated in chemoresistant CSCs versus non-CSCs and demonstrate its crucial relevance for CSC biology. In particular, overexpression of miR-17-92 reduced CSC self-renewal capacity, in vivo tumourigenicity and chemoresistance by targeting multiple NODAL/ACTIVIN/TGF-β1 signalling cascade members as well as directly inhibiting the downstream targets p21, p57 and TBX3. Overexpression of miR-17-92 translated into increased CSC proliferation and their eventual exhaustion via downregulation of p21 and p57. Finally, the translational impact of our findings could be confirmed in preclinical models for pancreatic cancer. Conclusions Our findings therefore identify the miR-17-92 cluster as a functionally determining family of miRNAs in CSCs, and highlight the putative potential of developing modulators of this cluster to overcome drug resistance in pancreatic CSCs.

AB - Objective Cancer stem cells (CSCs) represent the root of many solid cancers including pancreatic ductal adenocarcinoma, are highly chemoresistant and represent the cellular source for disease relapse. However the mechanisms involved in these processes still need to be fully elucidated. Understanding the mechanisms implicated in chemoresistance and metastasis of pancreatic cancer is critical to improving patient outcomes. Design Micro-RNA (miRNA) expression analyses were performed to identify functionally defining epigenetic signatures in pancreatic CSC-enriched sphere-derived cells and gemcitabine-resistant pancreatic CSCs. Results We found the miR-17-92 cluster to be downregulated in chemoresistant CSCs versus non-CSCs and demonstrate its crucial relevance for CSC biology. In particular, overexpression of miR-17-92 reduced CSC self-renewal capacity, in vivo tumourigenicity and chemoresistance by targeting multiple NODAL/ACTIVIN/TGF-β1 signalling cascade members as well as directly inhibiting the downstream targets p21, p57 and TBX3. Overexpression of miR-17-92 translated into increased CSC proliferation and their eventual exhaustion via downregulation of p21 and p57. Finally, the translational impact of our findings could be confirmed in preclinical models for pancreatic cancer. Conclusions Our findings therefore identify the miR-17-92 cluster as a functionally determining family of miRNAs in CSCs, and highlight the putative potential of developing modulators of this cluster to overcome drug resistance in pancreatic CSCs.

UR - http://www.scopus.com/inward/record.url?scp=84954403744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954403744&partnerID=8YFLogxK

U2 - 10.1136/gutjnl-2014-308470

DO - 10.1136/gutjnl-2014-308470

M3 - Article

VL - 64

SP - 1936

EP - 1948

JO - Gut

JF - Gut

SN - 0017-5749

IS - 12

ER -